Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CCXI
Churchill Capital Corp XI
$15.93
+3.4%		$13.33
$10.07
▼
$19.69
$1.14B1.221.32 million shs3.93 million shs
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$11.55
-0.2%		$10.99
$9.77
▼
$18.30
$2.02B0.2345,108 shs21,132 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CCXI
Churchill Capital Corp XI
-0.45%+6.06%-19.37%+50.68%+1,539,999,900.00%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
+0.35%+3.49%+1.32%-13.69%-32.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CCXI
Churchill Capital Corp XI
$15.93
+3.4%		$13.33
$10.07
▼
$19.69
$1.14B1.221.32 million shs3.93 million shs
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$11.55
-0.2%		$10.99
$9.77
▼
$18.30
$2.02B0.2345,108 shs21,132 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CCXI
Churchill Capital Corp XI
-0.45%+6.06%-19.37%+50.68%+1,539,999,900.00%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
+0.35%+3.49%+1.32%-13.69%-32.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CCXI
Churchill Capital Corp XI
1.00
SellN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
2.17
Hold$14.8728.72% Upside

Current Analyst Ratings Breakdown

Latest CCXI and HCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
CCXI
Churchill Capital Corp XI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E)
7/31/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D)
7/23/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$16.00 ➝ $14.00
7/17/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D+) ➝ Hold (C-)
7/7/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$20.00 ➝ $17.00
6/29/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D+)
5/28/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$13.60
5/6/2026
CCXI
Churchill Capital Corp XI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSell (E)
(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CCXI
Churchill Capital Corp XI
$37.20M30.56N/AN/AN/A∞
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$548.51M3.67$2.69 per share4.29$7.31 per share1.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CCXI
Churchill Capital Corp XI
N/A-$1.89N/AN/AN/AN/AN/AN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$456.91MN/AN/A52.50N/AN/AN/AN/AN/A

Latest CCXI and HCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026H1 2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$0.1450$0.05-$0.0950$0.05$304.16 million$139.14 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CCXI
Churchill Capital Corp XI
N/AN/AN/AN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CCXI
Churchill Capital Corp XI
N/AN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
0.06
5.64
5.50

Institutional Ownership

CompanyInstitutional Ownership
CCXI
Churchill Capital Corp XI
81.09%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
8.82%

Insider Ownership

CompanyInsider Ownership
CCXI
Churchill Capital Corp XI
8.30%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
3.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
CCXI
Churchill Capital Corp XI
N/A71.36 millionN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
1,796174.47 million168.19 millionNot Optionable

Recent News About These Companies

HUTCHMED (NASDAQ:HCM) Announces Earnings Results
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hutchmed-nasdaqhcm-announces-earnings-results-2026-07-30/
HUTCHMED Reports 2026 Interim Results
July 31, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/07/30/10422590.htm
HUTCHMED (China) Limited (HCM) Q2 2026 Earnings Call Transcript
July 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4928139-hutchmed-china-limited-hcm-q2-2026-earnings-call-transcript
HUTCHMED H1 Earnings Call Highlights
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hutchmed-h1-earnings-call-highlights-2026-07-30/
HUTCHMED (China) Limited 2026 Q2 - Results - Earnings Call Presentation
July 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4927756-hutchmed-china-limited-2026-q2-results-earnings-call-presentation
Hutchmed China Ltd. Reveals Fall In H1 Income
July 30, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69170470-hutchmed-china-ltd-reveals-fall-in-h1-income-020.htm
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Rating of "Hold" from Brokerages
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hutchmed-china-limited-sponsored-adr-nasdaqhcm-receives-average-rating-of-hold-from-brokerages-2026-07-30/
HUTCHMED (HCM) Projected to Release Earnings on Thursday
July 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hutchmed-hcm-projected-to-release-earnings-on-thursday-2026-07-23/
Hutchmed: Bullish On Their Commercial Prospects And Pipeline Catalysts
July 19, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4923287-hutchmed-stock-bullish-commercial-prospects-pipeline-catalysts
HUTCHMED (NASDAQ:HCM) Stock Price Down 6% - Here's Why
July 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hutchmed-nasdaqhcm-stock-price-down-6-heres-why-2026-07-17/
HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification
July 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/02/3321131/0/en/hutchmed-announces-nmpa-approval-for-orpathys-for-the-treatment-of-gastric-cancer-patients-with-met-amplification.html
HUTCHMED to Announce 2026 Half-Year Financial Results
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3319446/0/en/hutchmed-to-announce-2026-half-year-financial-results.html
HUTCHMED's experimental drug shows durable responses in advanced bile duct cancer trial
June 25, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/hutchmeds-experimental-drug-shows-durable-responses-in-advanced-bile-duct-cancer-trial/ar-AA26xHm7
Syndio Acquires Embrace.ai
June 23, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260623406678/en/syndio-acquires-embrace.ai/
isolved Introduces Autonomous AI Agents Built to Own HR Outcomes — Brings Unified HCM Platform to Anthropic's Claude Connectors Directory
June 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/16/3312891/0/en/isolved-Introduces-Autonomous-AI-Agents-Built-to-Own-HR-Outcomes-Brings-Unified-HCM-Platform-to-Anthropic-s-Claude-Connectors-Directory.html
Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
June 16, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/edgewise-therapeutics-announces-positive-top-line-data-from-12-week-phase-2-cirrus-hcm-trial-with-edg-7500-in-obstructive-and-nonobstructive-hypertrophic-cardiomyopathy-hcm-302801108.html
isolved Honors Top-Performing Partners at Annual Connect for Partners Event
June 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/16/3312225/0/en/isolved-honors-top-performing-partners-at-annual-connect-for-partners-event.html
isolved Introduces New Strategic Marketplace Partners at Connect 2026, Extending People Cloud™ Capabilities for Employers and Employees
June 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/15/3311996/0/en/isolved-introduces-new-strategic-marketplace-partners-at-connect-2026-extending-people-cloud-capabilities-for-employers-and-employees.html
Paychex Recognized as a Top WorkTech Company by TIME
June 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/15/3311865/0/en/paychex-recognized-as-a-top-worktech-company-by-time.html
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
June 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/12/3310859/0/en/hutchmed-highlights-sovleplenib-eslim-02-phase-iii-data-in-warm-antibody-autoimmune-hemolytic-anemia-presented-at-eha-2026-congress.html
HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting
May 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/22/3299860/0/en/hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Churchill Capital Corp XI NASDAQ:CCXI

$15.93 +0.53 (+3.44%)
Closing price 04:00 PM Eastern
Extended Trading
$15.70 -0.23 (-1.43%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Churchill Capital Corp XI is a blank check company.

HUTCHMED stock logo

HUTCHMED NASDAQ:HCM

$11.55 -0.02 (-0.17%)
Closing price 04:00 PM Eastern
Extended Trading
$11.56 +0.01 (+0.09%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas